Standard
Assessing Long-Term Survival Benefits of Immune Checkpoint Inhibitors Using the Net Survival Benefit. / Péron, Julien; Lambert, Alexandre; Munier, Stephane; Ozenne, Brice; Giai, Joris; Roy, Pascal; Dalle, Stephane; Machingura, Abigirl; Maucort-Boulch, Delphine; Buyse, Marc.
I:
National Cancer Institute. Journal (Print), Bind 111, Nr. 11, 2019, s. 1186-1191.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Péron, J, Lambert, A, Munier, S
, Ozenne, B, Giai, J, Roy, P, Dalle, S, Machingura, A, Maucort-Boulch, D & Buyse, M 2019, '
Assessing Long-Term Survival Benefits of Immune Checkpoint Inhibitors Using the Net Survival Benefit',
National Cancer Institute. Journal (Print), bind 111, nr. 11, s. 1186-1191.
https://doi.org/10.1093/jnci/djz030APA
Péron, J., Lambert, A., Munier, S.
, Ozenne, B., Giai, J., Roy, P., Dalle, S., Machingura, A., Maucort-Boulch, D., & Buyse, M. (2019).
Assessing Long-Term Survival Benefits of Immune Checkpoint Inhibitors Using the Net Survival Benefit.
National Cancer Institute. Journal (Print),
111(11), 1186-1191.
https://doi.org/10.1093/jnci/djz030Vancouver
Péron J, Lambert A, Munier S
, Ozenne B, Giai J, Roy P o.a.
Assessing Long-Term Survival Benefits of Immune Checkpoint Inhibitors Using the Net Survival Benefit.
National Cancer Institute. Journal (Print). 2019;111(11):1186-1191.
https://doi.org/10.1093/jnci/djz030Author
Péron, Julien ; Lambert, Alexandre ; Munier, Stephane ; Ozenne, Brice ; Giai, Joris ; Roy, Pascal ; Dalle, Stephane ; Machingura, Abigirl ; Maucort-Boulch, Delphine ; Buyse, Marc. / Assessing Long-Term Survival Benefits of Immune Checkpoint Inhibitors Using the Net Survival Benefit. I: National Cancer Institute. Journal (Print). 2019 ; Bind 111, Nr. 11. s. 1186-1191.
Bibtex
@article{abcb122624894958984d85e9c0b859d8,
title = "Assessing Long-Term Survival Benefits of Immune Checkpoint Inhibitors Using the Net Survival Benefit",
author = "Julien P{\'e}ron and Alexandre Lambert and Stephane Munier and Brice Ozenne and Joris Giai and Pascal Roy and Stephane Dalle and Abigirl Machingura and Delphine Maucort-Boulch and Marc Buyse",
year = "2019",
doi = "10.1093/jnci/djz030",
language = "English",
volume = "111",
pages = "1186--1191",
journal = "National Cancer Institute. Journal (Print)",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "11",
}
RIS
TY - JOUR
T1 - Assessing Long-Term Survival Benefits of Immune Checkpoint Inhibitors Using the Net Survival Benefit
AU - Péron, Julien
AU - Lambert, Alexandre
AU - Munier, Stephane
AU - Ozenne, Brice
AU - Giai, Joris
AU - Roy, Pascal
AU - Dalle, Stephane
AU - Machingura, Abigirl
AU - Maucort-Boulch, Delphine
AU - Buyse, Marc
PY - 2019
Y1 - 2019
U2 - 10.1093/jnci/djz030
DO - 10.1093/jnci/djz030
M3 - Journal article
C2 - 30838402
VL - 111
SP - 1186
EP - 1191
JO - National Cancer Institute. Journal (Print)
JF - National Cancer Institute. Journal (Print)
SN - 0027-8874
IS - 11
ER -
